Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations, page-203

mmq1 besides the thumb up . Didn’t anyone noticed that Akki posts on ANP drugs
are mostly (when related to drugs 99% I should say) negative regardless ATL 1102 had very and unexpected good final results on DMD and in addition it has been confirmed that the same drug can be utilised for other pathologies. The only time is on a positive defensive action is to speak up for the diamond the way ANP is managed and that the MD regardless is doing his professional best the development will take ages.
Food for thought